Organogenesis Holdings Stock Price Prediction

ORGO Stock  USD 3.90  0.06  1.52%   
The RSI of Organogenesis Holdings' the stock price is about 67. This indicates that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Organogenesis, making its price go up or down.

Oversold Vs Overbought

67

 
Oversold
 
Overbought
The successful prediction of Organogenesis Holdings' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Organogenesis Holdings, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Organogenesis Holdings' stock price prediction:
Quarterly Earnings Growth
3.5
EPS Estimate Next Quarter
(0.01)
EPS Estimate Current Year
0.11
EPS Estimate Next Year
0.15
Wall Street Target Price
4.7
Using Organogenesis Holdings hype-based prediction, you can estimate the value of Organogenesis Holdings from the perspective of Organogenesis Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Organogenesis Holdings to buy its stock at a price that has no basis in reality. In that case, they are not buying Organogenesis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Organogenesis Holdings after-hype prediction price

    
  USD 3.84  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Organogenesis Holdings Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Intrinsic
Valuation
LowRealHigh
0.173.458.44
Details
4 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.030.030.03
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Organogenesis Holdings. Your research has to be compared to or analyzed against Organogenesis Holdings' peers to derive any actionable benefits. When done correctly, Organogenesis Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Organogenesis Holdings.

Organogenesis Holdings After-Hype Price Prediction Density Analysis

As far as predicting the price of Organogenesis Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Organogenesis Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Organogenesis Holdings, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Organogenesis Holdings Estimiated After-Hype Price Volatility

In the context of predicting Organogenesis Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Organogenesis Holdings' historical news coverage. Organogenesis Holdings' after-hype downside and upside margins for the prediction period are 0.19 and 8.83, respectively. We have considered Organogenesis Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.90
3.84
After-hype Price
8.83
Upside
Organogenesis Holdings is risky at this time. Analysis and calculation of next after-hype price of Organogenesis Holdings is based on 3 months time horizon.

Organogenesis Holdings Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Organogenesis Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organogenesis Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Organogenesis Holdings, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.59 
4.99
  0.06 
  0.06 
7 Events / Month
11 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.90
3.84
1.54 
4,990  
Notes

Organogenesis Holdings Hype Timeline

Organogenesis Holdings is now traded for 3.90. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.06. Organogenesis is forecasted to decline in value after the next headline, with the price expected to drop to 3.84. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.54%, whereas the daily expected return is now at 0.59%. The volatility of related hype on Organogenesis Holdings is about 5019.53%, with the expected price after the next announcement by competition of 3.96. About 43.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.88. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Organogenesis Holdings recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.
Check out Organogenesis Holdings Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Organogenesis Holdings Related Hype Analysis

Having access to credible news sources related to Organogenesis Holdings' direct competition is more important than ever and may enhance your ability to predict Organogenesis Holdings' future price movements. Getting to know how Organogenesis Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Organogenesis Holdings may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SHPHShuttle Pharmaceuticals(0.09)5 per month 0.00 (0.15) 10.08 (11.66) 50.96 
MNKMallinckrodt Plc(0.04)2 per month 13.99  0.03  12.50 (30.95) 504.19 
LSDILucy Scientific Discovery(0.18)1 per month 27.98  0.21  550.00 (81.82) 3,998 
ALIMAlimera Sciences 0.01 7 per month 0.37  0.12  3.28 (0.72) 82.36 
LFCRLifecore Biomedical 0.47 9 per month 4.48  0.14  9.76 (5.78) 25.69 
RDHLRedhill Biopharma(0.36)10 per month 3.67  0.01  9.81 (6.57) 29.17 
TAROTaro Pharmaceutical Industries 0.03 8 per month 0.12 (0.35) 0.50 (0.35) 1.25 
COLLCollegium Pharmaceutical(0.86)8 per month 0.00 (0.17) 3.23 (4.47) 12.29 
ADMPAdamis Pharma 0.05 4 per month 0.00 (0.28) 8.72 (11.60) 40.76 
TKNOAlpha Teknova(0.35)6 per month 4.81  0.12  12.84 (8.06) 32.06 
GHSIGuardion Health Sciences 0.00 0 per month 8.11  0.05  18.66 (7.94) 101.05 
PTPIPetros Pharmaceuticals(0.02)4 per month 0.00 (0.07) 7.41 (7.89) 45.54 
ALKSAlkermes Plc(0.13)8 per month 2.08 (0.02) 4.14 (3.59) 9.74 
NBIXNeurocrine Biosciences(0.74)8 per month 0.00 (0.13) 3.10 (2.10) 18.87 
ITCIIntracellular Th 3.45 8 per month 1.32  0.07  3.04 (2.53) 16.17 
DCPHDeciphera Pharmaceuticals LLC 0.00 0 per month 0.00 (0.15) 3.27 (3.25) 9.66 
DVAXDynavax Technologies 0.45 8 per month 2.16  0.05  3.69 (2.93) 17.05 

Organogenesis Holdings Additional Predictive Modules

Most predictive techniques to examine Organogenesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Organogenesis using various technical indicators. When you analyze Organogenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Organogenesis Holdings Predictive Indicators

The successful prediction of Organogenesis Holdings stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Organogenesis Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Organogenesis Holdings based on analysis of Organogenesis Holdings hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Organogenesis Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Organogenesis Holdings's related companies.
 2022 2023 2024 (projected)
Days Sales Outstanding72.4169.151.53
PTB Ratio1.321.931.83

Story Coverage note for Organogenesis Holdings

The number of cover stories for Organogenesis Holdings depends on current market conditions and Organogenesis Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Organogenesis Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Organogenesis Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Organogenesis Holdings Short Properties

Organogenesis Holdings' future price predictability will typically decrease when Organogenesis Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Organogenesis Holdings often depends not only on the future outlook of the potential Organogenesis Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Organogenesis Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding132.7 M
Cash And Short Term Investments104.3 M
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out Organogenesis Holdings Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.5
Earnings Share
(0.05)
Revenue Per Share
3.446
Quarterly Revenue Growth
0.061
Return On Assets
0.0164
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.